Home > Clinical Trials

Saved trials

ACTIVE_NOT_RECRUITING
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
Deep Vein Thrombosis


Pulmonary Embolism
RECRUITING
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
920 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation (AF)


VTE
TERMINATED
NCT06231693
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
2 Enrollment(s)
2 Study location(s)
OBSERVATIONAL (None)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT03273413
Statin Therapy in Patients With Early Stage ADPKD
150 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
ADPKD


Autosomal Dominant Polycystic Kidney
COMPLETED
NCT01717586
Pravastatin for Prevention of Preeclampsia
48 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE1)
Preeclampsia
RECRUITING
NCT06837792
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
141 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
RECRUITING
NCT06947707
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
1,486 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Cerebral Venous Thrombosis


Anticoagulants and Thrombotic Disorders


Anticoagulation Treatment


Anticoagulant Therapy


Anticoagulant Drugs


NOACs


Anticoagulant Prophylaxis/Therapy


Anticoagulation With NOAC


Anticoagulation With Direct Oral Anticoagulants
COMPLETED
NCT05122455
Effects of Edoxaban on Platelet Aggregation
61 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2|||PHASE3)
SCAD


AMI